Roxyapatite inside porous TiO2 layer by micro-arc oxidation coupled with electrophoretic deposition. Acta Biomater, 2009; five: 219605 27. Wei DQ, Zhou Y, Jia DC et al: Characteristic and in vitro bioactivity of a microarc-oxidized TiO2-based coating soon after chemical therapy. Acta Biomater, 2007; 3: 8177 28. Matykina E, Arrabal R, Skeldon P et al: Transmission electron microscopy of coatings formed by plasma electrolytic oxidation of titanium. Acta Biomater, 2009; five: 13566 29. Song WH, Ryu HS, Hong SH: Apatite induction on Ca-containing titania formed by micro-arc oxidation. J Am Ceram Soc, 2005; 88: 26424 30. Han Y, Sun JF, Huang X. Formation mechanism of HA-based coatings by microarc oxidation. Electrochem Commun, 2008; ten: 5103 31. Yao ZQ, Ivanisenko Y, Diemant et al: Synthesis and properties of hydroxyapatite-containing porous titania coating on ultrafine-grained titanium by micro-arc oxidation. Acta Biomater, 2010; 6(7): 28165 32. Song WH, Jun YK, Han Y et al: Biomimetic apatite coating on micro-arc oxidized titania. Biomaterials, 2004; 25: 3341This operate is licensed below a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseIndexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System] [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica] [Chemical Abstracts/CAS] [Index Copernicus]
Europe PMC Funders GroupAuthor Manuscript N Engl J Med. Author manuscript; out there in PMC 2016 December 09.Published in final edited kind as: N Engl J Med. 2016 June 9; 374(23): 2209221. doi:ten.1056/NEJMoa1516192.Europe PMC Funders Author Manuscripts Europe PMC Funders Author ManuscriptsGenomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Ph.D.#, Moritz Gerstung, Ph.D.#, Lars Bullinger, M.D., Verena I. Gaidzik, M.D., Peter Paschka, M.D., Nicola D.SMCC Biological Activity Roberts, B.Enterolactone Data Sheet Sc., Nicola E. Potter, Ph.D., Michael Heuser, M.D., Felicitas Thol, M.D., Niccolo Bolli, M.D., Ph.D., Gunes Gundem, Ph.D., Peter Van Loo, Ph.D., Inigo Martincorena, Ph.D., Peter Ganly, B.M., B.Ch., Ph.D., Laura Mudie, B.Sc., Stuart McLaren, B.Sc., Sarah O’Meara, B.Sc., Keiran Raine, M.Sc., David R. Jones, M.Sc., Jon W. Teague, B.Sc., Adam P. Butler, B.Sc., Mel F. Greaves, Ph.D., Arnold Ganser, M.D., Konstanze D ner, M.D., Richard F. Schlenk, M.D., Hartmut D ner, M.D.#, and Peter J. Campbell, M.B., Ch.B., Ph.D.# Cancer Genome Project, Wellcome Trust Sanger Institute (E.PMID:23357584 P., M.G., N.D.R., N.B., G.G., P.V.L., I.M., L.M., S.M., S.O., K.R., D.R.J., J.W.T., A.P.B., P.J.C.), along with the European Bioinformatics Institute, European Molecular Biology Laboratory (EMBL-EBI) (M.G.), Hinxton, the Centre for Evolution and Cancer, Institute of Cancer Analysis, London (N.E.P., M.F.G.), and also the Division of Haematology, University of Cambridge, Cambridge (N.B.) — all within the United kingdom; the Departments of Epidemiology and Biostatistics and Cancer Biology, the Center for Molecular Oncology along with the Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York (E.P.); the Division of Internal Medicine III, Ulm University, Ulm (L.B., V.I.G., P.P., K.D., R.F.S., H.D.), as well as the Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Health-related School, Hannover (M.H., F.T., A.G.) — each in Germany; the Division of Hematology, Fondazione IRCCS, Istituto Nazionale dei Tumori, and Division of Oncology and Onco-Hematology, University of Milan, Milan (N.B.); the Division of Human.